BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6159910)

  • 1. Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
    Norfolk D; Child JA; Cooper EH; Kerruish S; Ward AM
    Br J Cancer; 1980 Oct; 42(4):510-5. PubMed ID: 6159910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
    Child JA; Crawford SM; Norfolk DR; O'Quigley J; Scarffe JH; Struthers LP
    Br J Cancer; 1983 Jan; 47(1):111-4. PubMed ID: 6185132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the determination of beta-2-microglobulin in the monitoring of myeloma. Apropos of 290 determinations].
    Kaltwasser P; Sauger F; Le Loet X; Pasquis P; Monconduit M; Deshayes P
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):359-63. PubMed ID: 6179150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
    Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
    Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
    Cuzick J; Cooper EH; MacLennan IC
    Br J Cancer; 1985 Jul; 52(1):1-6. PubMed ID: 3893505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
    Linkesch W; Ludwig H
    Cancer Detect Prev; 1983; 6(1-2):297-301. PubMed ID: 6192921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of beta 2-microglobulin in myeloma patients.
    Engström W; Hyldahl L; Wahrgren P
    Clin Chim Acta; 1980 Dec; 108(3):369-74. PubMed ID: 6162592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.
    Scarffe JH; Anderson H; Palmer MK; Crowther D
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1361-4. PubMed ID: 6357802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum beta-2-microglobulin estimation as an indicator of the glomerular filtration rate.
    Jialal I; Nathoo BC; Bejai S; Joubert SM
    S Afr Med J; 1982 Jun; 61(25):953-4. PubMed ID: 6178173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
    Brenning G; Wibell L; Bergström R
    Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment serum beta 2-microglobulin in multiple myeloma.
    Brenning G; Simonsson B; Källander C; Ahre A
    Br J Haematol; 1986 Jan; 62(1):85-93. PubMed ID: 3510657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta-2-microglobulin levels in urological cancer.
    Bunning RA; Haworth SL; Cooper EH
    J Urol; 1979 May; 121(5):624-5. PubMed ID: 86616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [beta2-Microglobulin and monoclonal gammapathies (author's transl)].
    Belleville F; Bertrand F; Nabet P
    Pathol Biol (Paris); 1978 Sep; 26(6):348-50. PubMed ID: 83581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.